Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to whether they subsequently switched or not.

TNF, tumor necrosis factor; BMI, body mass index; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; INH, isoniazid; NSAIDs, non-steroidal anti-inflammatory drugs; DMARDs, disease-modifying anti-rheumatic drugs. Continuous variables are shown as medians and interquartile range.
Baseline characteristics and laboratory findings of patients starting their first TNF-α inhibitor according to whether they subsequently switched or not.